Pathophysiology of acute experimental pancreatitis: Lessons from genetically engineered animal models and new molecular approaches

Episode von Medizin - Open Access LMU - Teil 14/22 von Ludwig-Maximilians-Universität München · 1. Januar 2005

The incidence of acute pancreatitis is growing and worldwide population-based studies report a doubling or tripling since the 1970s. 25% of acute pancreatitis are severe and associated with histological changes of necrotizing pancreatitis. There is still no specific medical treatment for acute pancreatitis. The average mortality resides around 10%. In order to develop new specific medical treatment strategies for acute pancreatitis, a better understanding of the pathophysiology during the onset of acute pancreatitis is necessary. Since it is difficult to study the early acinar events in human pancreatitis, several animal models of acute pancreatitis have been developed. By this, it is hoped that clues into human pathophysiology become possible. In the last decade, while employing molecular biology techniques, a major progress has been made. The genome of the mouse was recently sequenced. Various strategies are possible to prove a causal effect of a single gene or protein, using either gain-of-function (i.e., overexpression of the protein of interest) or loss-of-function studies (i.e., genetic deletion of the gene of interest). The availability of transgenic mouse models and gene deletion studies has clearly increased our knowledge about the pathophysiology of acute pancreatitis and enables us to study and confirm in vitro findings in animal models. In addition, transgenic models with specific genetic deletion or overexpression of genes help in understanding the role of one specific protein in a cascade of inflammatory processes such as pancreatitis where different proteins interact and co-react. This review summarizes the recent progress in this field. Copyright (c) 2005 S. Karger AG, Basel.

Weitere Episoden von „Medizin - Open Access LMU - Teil 14/22“

• A role for MCP-1/CCR2 in interstitial lung disease in children 1. Januar 2005
• A simple approach for protein name identification: prospects and limits 1. Januar 2005
• An extrahippocampal projection from the dentate gyrus to the olfactory tubercle 1. Januar 2005
• Association between cognitive performance and cortical glucose metabolism in patients with mild Alzheimer's disease 1. Januar 2005
• Chemokine receptor CCR1: A new target for progressive kidney disease 1. Januar 2005
• Comparing the clinical effectiveness of different new-born hearing screening strategies. A decision analysis 1. Januar 2005
• Concerted upregulation of CLP36 and smooth muscle actin protein expression in human endometrium during decidualization 1. Januar 2005
• Effect of stress doses of hydrocortisone on S-100B vs. interleukin-8 and polymorphonuclear elastase levels in human septic shock 1. Januar 2005
• Expression profiles of hydrophobic surfactant proteins in children with diffuse chronic lung disease 1. Januar 2005
• Fluorescence in situ hybridization to chromosomes as a tool to understand human and primate genome evolution 1. Januar 2005
• Follow-up investigations of tau protein and S-100B levels in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease 1. Januar 2005
• Gene expression profile and synovial microcirculation at early stages of collagen-induced arthritis 1. Januar 2005
• Genetic association of CDC2 with cerebrospinal fluid tau in Alzheimer's disease 1. Januar 2005
• Hahnemann's legacy in a new light - A systematic approach to the Organon of Medicine 1. Januar 2005
• 3D Analysis of chromosome architecture: advantages and limitations with SEM 1. Januar 2005

Alle Episoden von Medizin - Open Access LMU - Teil 14/22 · Mehr Bildung-Podcasts